Thai FDA publishes the Type 2 checklist for seven-year drug renewals — site names and sequence links decide it

Which filings this checklist is for

On 18 September 2026 the Thai FDA Medicines Regulation Division posted the submission checklist for Type 2 renewals of human modern drug registrations. The attachment is a 23-page form.

The first page draws the boundary tightly.

• Generic, new generic and low-risk medicines whose dossier is prepared under Annex 2
• Registrations renewed every seven years under section 86/2 of the Drug Act (6th amendment) B.E. 2562
• Of those, products registered from 13 October B.E. 2562 (13 October 2019) onwards
• Whose quality documentation follows ASEAN or ICH guidelines and has been kept current with approved variations
• Transfer registrations whose quality dossier has not been updated to ASEAN or ICH guidelines are excluded

The underlying instrument is the FDA notification of B.E. 2569 on the documents evidencing quality, efficacy and safety at renewal, and the criteria and conditions for assessing them.

Three places where filings actually fail

Reading what the form asks for shows where deficiencies arise.

First, the tracking table has to point at the latest approved version. The table header carries the trade name, active ingredient and strength, and for each document you must state the sequence in which the current approved version was granted, or hyperlink to it. Where a registration was varied and its baseline built afterwards, the document table has to be rebuilt to the checklist's format. The form has dedicated columns for the latest approved sequence and the Yor. 5 receipt number.

Attached to this is an instruction that looks trivial and is not — name files in English. The reason is given: otherwise documents cannot be opened in the Docubridge system.

Second, only an application form generated in Skynet is accepted. A separately prepared form does not qualify.

Third, manufacturing site details must match the other documents character for character. The application records the applicant's name and address as they appear on the manufacturing or import licence, the finished product manufacturer, primary and secondary packaging sites, the site responsible for batch release, and any other relevant manufacturers. The checklist expressly directs that these entries be cross-checked against the CPP, GMP certificate, GMP clearance, labelling, package insert and registration data form. The older the registration, the more likely a site name or address has drifted between documents — and renewal is where all of it surfaces at once.

Work the preparation backwards

Starting from document titles tends to produce a filing with the links missing. Reversing the order — first establishing which sequence holds the current approved version, then laying the checklist items over it — cuts omissions. What the reviewer examines is not new data but the accuracy and completeness of what was already approved.

The first page also asks whether an electronic baseline dossier to ASEAN or ICH eCTD has been prepared. For a registration without a baseline, that work comes before the renewal itself.

What has not been checked

This article is based on the first two of the checklist's 23 pages. The item-level requirements further in are not covered. Whether a specific product falls under Type 2, how the underlying notification's commencement and transitional provisions apply, and which form version is current at the time of filing all need case-by-case confirmation. The posting of a checklist is not itself the commencement of a new rule.